Clinical Study of Moxibustion for the Prevention of Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study was a prospective, multicenter, randomized controlled clinical study planned to recruit 266 hematological patients with allogeneic hematopoietic stem cell transplantation (allo-HSCT), who were randomly divided into two groups according to gender, type of transplantation, and type of primary disease. The control group was treated conventionally, and the experimental group increased moxibustion of Zhongji, Guanyuan and Qihai for 30 min qd starting on the first day after HSCT was performed until the 14th day after transplantation. Urine routine tests were performed at the time of admission, +1d, and +14d, and urine BK virus, JC virus, and adenovirus were tested at four time points, namely, +1d, +14 days, onset of hematuria symptoms, and remission of HC, respectively; routine urine tests were performed once every 7 days for all patients within 100days. For patients with Hemorrhagic cystitis (HC), daily severity grading, pain scoring, cystitis symptom scoring, use of antispasmodic and analgesic medications, and major TCM evidence were recorded with the aim of evaluating the efficacy of moxibustion in the prevention of HC in this patient population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 14
Maximum Age: 60
Healthy Volunteers: f
View:

• Patients are fully aware of the study, participate voluntarily and sign the informed consent form (ICF);

• Age: 14-60 years;

• Patients with pernicious blood diseases undergoing allo-HSCT using the MAC protocol or patients with severe aplastic anemia (Severe aplastic anemia; severeaplasticanimin, SAA) undergoing allo-HSCT;

Locations
Other Locations
China
Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
NOT_YET_RECRUITING
Hangzhou
Hematology Department, The First People's Hospital of Yunnan
RECRUITING
Kunming
Yi Zhang
RECRUITING
Wuhan
Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou
RECRUITING
Zhengzhou
Contact Information
Primary
Yi Zhang, Dr
zy188603@163.com
+86 15639790587
Time Frame
Start Date: 2024-03-21
Estimated Completion Date: 2026-06-30
Participants
Target number of participants: 266
Treatments
Experimental: Moxibustion
Active_comparator: Control
Related Therapeutic Areas
Sponsors
Leads: Yi Zhang
Collaborators: The First Affiliated Hospital of Zhengzhou University, First Affiliated Hospital of Zhejiang University, The First People's Hospital of Yunnan

This content was sourced from clinicaltrials.gov

Similar Clinical Trials